Trends in the association of Lambert-Eaton myasthenic syndrome with carcinoma.
Neurology
; 42(4): 848-50, 1992 Apr.
Article
en En
| MEDLINE
| ID: mdl-1314343
ABSTRACT
The Lambert-Eaton myasthenic syndrome (LEMS) is often associated with carcinoma. The exact number of patients with tumor has been reported to be as high as 70%. Recent clinical experience suggests that the actual number of patients with tumor may be substantially lower. We combined data from the clinical experience of the neuromuscular services at West Virginia University and the University of Virginia to determine the rate of occurrence of cancer in this disorder. We identified 28 patients with LEMS, and 14 had cancer. There is a distinct trend for a lower tumor frequency over the past decade, which suggests that the clinical manifestations of the disease may be changing.
Search on Google
Banco de datos:
MEDLINE
Asunto principal:
Síndrome Miasténico de Lambert-Eaton
/
Neoplasias
Tipo de estudio:
Risk_factors_studies
Límite:
Adult
/
Female
/
Humans
/
Male
/
Middle aged
Idioma:
En
Año:
1992
Tipo del documento:
Article